Impact BioMedical, Ownership
| IBO Stock | USD 1.85 0.08 4.15% |
Impact |
Impact Stock Ownership Analysis
About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Impact BioMedical, had not issued any dividends in recent years. To learn more about Impact BioMedical, call JD Esq at 585-325-3610 or check out https://www.impactbiomedinc.com.Impact BioMedical, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Impact BioMedical, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Impact BioMedical,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Impact BioMedical, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dss, Inc. 2 days ago Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.2578 subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.61 subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 550 shares of Impact BioMedical, at 2.625 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 5000 shares by Dss, Inc. of Impact BioMedical, at 3.017 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 200 shares by Dss, Inc. of Impact BioMedical, at 2.8 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 500 shares by Dss, Inc. of Impact BioMedical, at 2.757 subject to Rule 16b-3 | ||
Dss, Inc. over three months ago Acquisition by Dss, Inc. of 1000 shares of Impact BioMedical, at 2.33 subject to Rule 16b-3 |
Pair Trading with Impact BioMedical,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Moving against Impact Stock
| 0.57 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.55 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.52 | LLY | Eli Lilly | PairCorr |
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.